Roughly 8.4 million people worldwide were living with type 1 diabetes as of 2021, and that number is climbing fast. In the United States alone, about 2.1 million people have been diagnosed, including 1.8 million adults and 314,000 children and adolescents. Type 1 diabetes accounts for roughly 5 to 6% of all diabetes cases, making it far less common than type 2, which represents over 90% of diagnoses.
Global Numbers and Why They’re Rising
An estimated half a million people are newly diagnosed with type 1 diabetes each year, and that figure is growing. Over the past three decades, diagnoses have risen in nearly every country, across all age groups, and in both wealthy and low-income nations. Better diagnostic tools and greater awareness explain part of the increase, but researchers say that alone doesn’t account for the trend. Something is driving more cases, and the reasons remain poorly understood.
Longer lifespans and lower mortality rates among people with type 1 diabetes also contribute to the rising total. More people are being diagnosed, and those who have it are living longer, so the global count keeps compounding. Modeling studies project the worldwide number could reach 13.5 to 17.4 million by 2040, potentially doubling the 2021 estimate.
Type 1 vs. Type 2: How the Numbers Compare
Type 1 diabetes is relatively rare when measured against the broader diabetes population. The World Health Organization estimates that more than 95% of all people with diabetes have type 2. In the U.S., a CDC analysis put the split at about 5.8% type 1 and 90.9% type 2 among diagnosed adults, with the remainder classified as other types. That gap reflects fundamental differences between the two conditions: type 1 is an autoimmune disease where the body destroys its own insulin-producing cells, while type 2 involves the body gradually losing the ability to use insulin effectively.
It’s Not Just a Childhood Disease
Type 1 diabetes is often thought of as a childhood condition, but the numbers tell a different story. Of the 2.1 million Americans with type 1, roughly 85% are adults. Only about 314,000 are children or adolescents. Adults can and do develop type 1 diabetes well into middle age and beyond, which creates a significant diagnostic problem.
Research from the United Kingdom found that about one-third of people who develop type 1 diabetes after age 30 are initially misdiagnosed with type 2. In those cases, nearly half reported being told they had type 2 diabetes and were not started on insulin right away. That delay matters. Without insulin, blood sugar can spike dangerously, and a life-threatening emergency called ketoacidosis can develop. Misdiagnosed patients also miss out on tools like insulin pumps and continuous glucose monitors that can dramatically improve daily management.
This pattern of misdiagnosis also means the true number of people with type 1 diabetes may be higher than official counts suggest. Some adults currently classified as having type 2 likely have type 1 or a related autoimmune form.
Life Expectancy With Type 1 Diabetes
People with type 1 diabetes live shorter lives on average than the general population, though the gap has been narrowing with advances in treatment and monitoring technology. A large meta-analysis found that men with type 1 diabetes have an average life expectancy of about 65 years, while women average about 68 years. For comparison, men and women without diabetes live to roughly 80 and 84, respectively. That’s a gap of about 14 to 16 years.
The range varies widely depending on access to care, blood sugar management, and whether complications develop over time. People diagnosed in recent decades, who benefit from modern insulin formulations and continuous monitoring, will likely see better outcomes than these averages suggest, since the data includes older cohorts managed with less precise tools.
The Financial Burden
Managing type 1 diabetes is expensive, even with insurance. A study of more than 65,000 privately insured patients found that adults and children with type 1 spend an average of $2,500 per year in out-of-pocket healthcare costs. About 8% spent more than $5,000 annually. Families of children with type 1 faced particularly high costs for diabetes supplies, averaging $823 per year compared to $445 for adults.
Insulin itself, while a major expense, accounted for only about 18% of total out-of-pocket spending. The rest went to test strips, continuous glucose monitors, pump supplies, doctor visits, and lab work. For the 2.1 million Americans managing this condition, those costs add up to billions in annual spending, and they fall disproportionately on families navigating the disease during childhood.
Why the Numbers Keep Climbing
The projected doubling of global cases by 2040 is not just a matter of population growth. Incidence rates are increasing relative to population size, meaning a larger share of people are developing type 1 diabetes than in previous generations. Diagnoses are also occurring at younger ages, which extends the total years each person lives with the condition and adds to the global prevalence count.
Researchers have explored a range of possible explanations, from viral infections that may trigger the autoimmune process to changes in gut bacteria, early childhood diet, and environmental exposures. None of these theories have been conclusively proven. What is clear from the data is that type 1 diabetes is not a static or shrinking problem. It is a growing one, affecting millions more people each decade, and the healthcare systems that support them will need to scale accordingly.